Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 227 clinical trials
featured
Advanced and Recurrent Endometrial Cancer (DUO-E)

People with cancer are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.

  • 22 views
  • 22 Jul, 2020
  • 1 location
featured
LEAP-001

People with endometrial carcinoma are asked to participate in a research study being conducted by Icahn School of Medicine at Mount Sinai.  

  • 64 views
  • 02 Aug, 2019
  • 1 location
featured
A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of INCMGA00012 (formerly MGA012) in Patients with Advanced Solid Tumors

500 mg every 4 weeks in patients with endometrial cancer, specifically either microsatellite instability-high (MSI-H) or mismatch repair deficient (dMMR). Additionally, every 3 week (Q3W) flat-dosing

cancer
endometrial carcinoma
primary cancer
measurable disease
  • 229 views
  • 14 Dec, 2020
  • 16 locations
featured
GOG 0258: A Randomized Phase III Trial of Cisplatin and Tumor Volume Directed Irradiation Followed by Carboplatin and Paclitaxel vs. Carboplatin and Paclitaxel for Optimally Debulked, Advanced Endometrial Carcinoma.

Endometrial Carcinoma.

  • 176 views
  • 08 Nov, 2020
  • 1 location
featured
An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors

An Open-Label, Dose-Escalation, Safety Tolerability Study of INCAGN01876 in Subjects With Advanced or Metastatic Solid Tumors

advanced solid tumor
solid tumors
solid tumor
  • 80 views
  • 08 Dec, 2020
  • 7 locations
Selective Targeting of Adjuvant Therapy for Endometrial Cancer (STATEC)

survival as compared to adjuvant therapy given to all women with high risk apparent stage 1 endometrial cancer.

cancer
hysterectomy
brachytherapy
carcinoma
mucinous adenocarcinoma
  • 33 views
  • 08 Nov, 2020
Biomarker Guided Treatment in Gynaecological Cancer

endometrial cancer. Predominantly, but not exclusively, such biomarkers have shown to be interesting in retrospective analysis of our large prospectively collected MoMaTEC1 series. Part 1

paclitaxel
cancer
lymphadenectomy
ovarian cancer
  • 40 views
  • 08 Nov, 2020
  • 1 location
Transvaginal Ultrasound in Women With Abnormal Uterine Bleeding

The objective of this study is to investigate the role of transvaginal ultrasound in detecting endometrial hyperplasia and endometrial cancer in women aged more than 35 presenting with

  • 0 views
  • 08 Nov, 2020
  • 1 location
MPA Versus Dydrogesterone for Management of Endometrial Hyperplasia Without Atypia

To compare the efficacy of Medroxyprogesterone Acetate with dydrogesterone in patients having endometrial hyperplasia (EH) without atypia.

  • 0 views
  • 13 Aug, 2020
  • 1 location
ONC201 in Recurrent or Metastatic Type II Endometrial Cancer Endometrial Cancer

This is a a Simon's two-stage, non-randomized, open label, 2-arm Phase II trial of ONC201 in women with metastatic or recurrent Type II endometrial cancer who failed at least 1 prior

renal function
neutrophil count
onc201
chemotherapy regimen
metastatic disease
  • 48 views
  • 17 Sep, 2020
  • 3 locations